Gimbach, S., Vogel, D., Fried, R., Faraone, S. V., Banaschewski, T., Buitelaar, J., . . . Ammer, R. (2023). The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions. European neuropsychopharmacology, 73, . https://doi.org/10.1016/j.euroneuro.2023.04.008
Chicago Style (17th ed.) CitationGimbach, Sophie, Daniel Vogel, Roland Fried, Stephen V. Faraone, Tobias Banaschewski, Jan Buitelaar, Manfred Döpfner, and Richard Ammer. "The Impact of the COVID-19 Pandemic on ADHD Medicine Consumption in 47 Countries and Regions." European Neuropsychopharmacology 73 (2023). https://doi.org/10.1016/j.euroneuro.2023.04.008.
MLA (9th ed.) CitationGimbach, Sophie, et al. "The Impact of the COVID-19 Pandemic on ADHD Medicine Consumption in 47 Countries and Regions." European Neuropsychopharmacology, vol. 73, 2023, https://doi.org/10.1016/j.euroneuro.2023.04.008.